Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
about
Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryThe enteric microbiome in hepatobiliary health and diseaseHepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalkPathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementImpact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapiesPathogenesis and clinical spectrum of primary sclerosing cholangitis.Treatment of autoimmune liver disease: current and future therapeutic options.Current status of therapy in autoimmune liver diseaseAdvances and controversies in the pathogenesis and management of primary sclerosing cholangitis.A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.Management of primary sclerosing cholangitis: conventions and controversiesPrimary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBDInteraction of gut microbiota with bile acid metabolism and its influence on disease states.Clinical features and management of primary sclerosing cholangitis.Hepatobiliary associations with inflammatory bowel disease.Treatment options for primary sclerosing cholangitis.Current management of primary sclerosing cholangitis in pediatric patients.Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.New treatment strategies for primary sclerosing cholangitis.Pathogenesis of primary sclerosing cholangitis.Primary sclerosing cholangitis: is any treatment worthwhile?Current pharmacotherapy for cholestatic liver disease.Primary sclerosing cholangitis: a review and update on therapeutic developments.Primary sclerosing cholangitis - the Norwegian experience.Primary sclerosing cholangitis: a clinical update.A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.Emerging treatments for primary sclerosing cholangitis.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis.Role of the microbiota and antibiotics in primary sclerosing cholangitis.The "gut microbiota" hypothesis in primary sclerosing cholangitis.Primary sclerosing cholangitis: diagnostic and management challenges.Cholangitis: Diagnosis, Treatment and Prognosis.Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.Searching for Bacterial Biofilm in Recurrent Cholangitis in Primary Sclerosing Cholangitis: A Case Presentation and Introduction of an Unexplored Disease Mechanism.
P2860
Q26766699-1C6F3827-3AD3-4D18-9C4A-EB08B9C18931Q26771816-7349B3E1-60A5-4B97-B398-1EB86031EC45Q26777426-A3C5AE9D-9119-4189-885C-D0365B7BC3A7Q26829300-B41F96FA-110A-4B91-93C6-B0D1D7D34CDBQ27015831-918A1327-E3A1-43BF-B63B-39AC522C66BFQ28076453-6CC6EF21-0DD6-411A-89E7-AFB8D965743DQ31170968-077FDB5E-0029-4C10-8804-0E4EC9C21C51Q33572623-2DA76EC6-09B8-4025-B3AB-CBB792B8101CQ34342199-39D03E90-AEB8-4AA5-997D-812E75BFD421Q34408950-E7157FC3-E3ED-4EB7-A883-BBB97741AA62Q35162765-79AABC24-AA92-42B7-8C6B-BAA248B79C6BQ35778052-09245239-D721-4768-8001-703C250F7EAFQ35962107-7D943FF8-7625-4D06-B1BE-D8A9D30A1774Q36025017-F65D4FC5-8731-46DF-AD6F-9D201AC9964CQ36204422-88B3FEF7-84E8-44F8-B592-EAF3285D5DADQ37182946-51F8A69C-46F3-40DB-8666-1959592D3B3EQ37636108-65DE48EB-2510-44A0-8659-05DAEA5D6F03Q37777156-01AE1316-A1B6-47CD-921D-545095F91315Q37847138-56F9C7DD-4E34-40FE-B594-823F38F45E23Q37866339-1B16A69C-21A9-4984-9123-7EC77BFE14D3Q37892297-DF84A6D2-2AEE-422C-8ECB-EBEC55FF6639Q37960966-0B318253-8A26-4C4D-A565-73C73A344205Q37962395-7A01900F-557F-4A0D-A7E2-811907832C5EQ38055205-2637CD49-9957-4E7C-9345-3A031880C2F3Q38077820-05328B70-8B63-4883-8F7E-7EEB7425DE00Q38417642-3F47F1AA-E8EE-406B-9157-159DCD8363D8Q38485235-3ED2B98C-63C1-4ADF-A8F9-3D4496787F2BQ38584285-AAC2175E-2185-4CE0-97C9-FFE644C47001Q38595151-119E67B5-CB19-499C-AF92-C71CCA5831E0Q38748384-C295DB2C-B04A-41B3-B964-B72E712CC63AQ38833243-4EA9D618-F5A8-4D5E-B80F-E25AA99E1C8EQ39177947-70B39916-DB36-4196-A05E-82BD3177329BQ42174395-A5062359-1A35-43E5-B878-6086AFDF2E9EQ42330826-F2CA7983-939F-4FF9-9BB6-8FEE62BE5689Q47112995-B0E04D69-F021-4F6A-AD97-E8AD60B7DB48Q47137991-B67735E9-4180-4784-AB66-163FD30E3449Q47162395-AB268B32-0CD7-44F4-A145-15FE4D81B090Q49896566-3492DEB2-578E-4FA8-AEA8-1CD414702834Q52972733-697766DC-A3EA-448B-A2B8-6765824D941CQ54982596-3C5FA7E1-CE7D-4B63-8368-FB49AD434B71
P2860
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@en
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@nl
type
label
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@en
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@nl
prefLabel
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@en
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Metronidazole and ursodeoxycho ...... ized placebo-controlled trial.
@en
P2093
Anna-Liisa Karvonen
Hannu Nuutinen
Heimo Nurmi
Matti Taavitsainen
Pekka Pikkarainen
Päivi Kärkkäinen
P2860
P304
P356
10.1002/HEP.20457
P407
P577
2004-12-01T00:00:00Z